CN Patent

CN101023064B — 作为蛋白激酶抑制剂的对映异构体纯的氨基杂芳基化合物

Assigned to SmithKline Beecham Ltd · Expires 2011-02-16 · 15y expired

What this patent protects

本发明提供了式1对映异构体纯的化合物， 以及其合成与使用方法。优选化合物为c-Met蛋白质激酶的有效抑制剂，且可用于治疗异常细胞生长病症，例如癌症。

USPTO Abstract

本发明提供了式1对映异构体纯的化合物， 以及其合成与使用方法。优选化合物为c-Met蛋白质激酶的有效抑制剂，且可用于治疗异常细胞生长病症，例如癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN101023064B
Jurisdiction
CN
Classification
—
Expires
2011-02-16
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.